Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Pharmacology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2125.1999.00067.x/fullpdf
Reference16 articles.
1. Doxazosin: an update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.;Fulton;Drugs,1995
2. A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.;Daae;Blood Press,1998
3. Doxazosin for benign prostatic hyperplasia: long-term efficacy and safety in hypertensive and normotensive patients. The Multicenter Study Group.;Lepor;J Urol,1997
4. Clinical correlation of maximal urinary flow rate and plasma doxazosin concentrations in the treatment of benign prostatic hyperplasia. Multicenter Study Group.;Fawzy;Urology,1999
5. A pharmacodynamic and pharmacokinetic assessment of a new α-adrenoreceptor antagonist, doxazosin (UK 33274) in normotensive subjects.;Elliott;Br J Clin Pharmacol,1982
Cited by 89 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR;Journal of Experimental & Clinical Cancer Research;2023-11-04
2. Preparation and evaluation of the doxazosin-bentonite composite as a pH-dependent controlled-release oral formulation;Applied Clay Science;2022-11
3. Role of α1‐blockers in the current management of hypertension;The Journal of Clinical Hypertension;2022-09
4. PK‐Sim®for Modeling Oral Drug Delivery of Modified‐Release Formulations;Oral Drug Delivery for Modified Release Formulations;2022-04-08
5. Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia;Medicine;2021-08-20
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3